BBLG Stock Earnings: Bone Biologics Misses EPS for Q1 2023
Source: iQoncept / Shutterstock
Bone Biologics (NASDAQ:BBLG) just reported results for the first quarter of 2023.
- Bone Biologics reported earnings per share of -$55.20. This was below the analyst estimate for EPS of -$4.80.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2023/12/bblg-stock-earnings-bone-biologics-for-q1-of-2023/.
©2023 InvestorPlace Media, LLC